Celyad Oncology SA ( CYAD) - Stock Earnings
Stock symbol CYAD is outdated, potentially delisted? Maybe it is available on other exchange?
CYAD Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q2 | -6.5 million USD | 0 USD |
| 2022Q3 | -13.4 million EUR | 0 EUR |
| 2022Q4 | -13.4 million EUR | 0 EUR |
CYAD Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2020 | -17.2 million USD | 5000 USD |
| 2021 | -26.5 million USD | 0 USD |
| 2022 | -40.9 million EUR | 0 EUR |
CYAD
Price: $0.47
52 week price:
Earnings Per Share: -4.12 USD
P/E Ratio: -3.91
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 37800
Ebitda: -22.5 millionMarket Capitalization: 16.4 million